- Aspira Women's Health Inc. (AWHL) entered into an amendment to its Securities Purchase Agreement on **September 19, 2025**, which requires the company to file a registration statement on Form S-1 by **September 30, 2025**, to register the shares of Common Stock and shares underlying the Warrants.  **[926617_0001493152-25-014925_ex10-1.htm:0]** **[926617_0001493152-25-014925_form8-k.htm:1]** 
- The amendment grants the purchasers, as a group, the right to appoint an aggregate of **three directors** to the Company's Board of Directors under specified conditions.  **[926617_0001493152-25-014925_form8-k.htm:1]** **[926617_0001493152-25-014925_ex10-1.htm:1]** 
- The Amended and Restated Series A Common Stock Warrants now feature a fixed exercise price of **$0.35 per share**, eliminate the cashless exercise option, extend the term from five to **six years** (until **September 19, 2031**), and change the initial exercisability to **six months** after the issuance date (starting **March 19, 2026**).  **[926617_0001493152-25-014925_form8-k.htm:1]** **[926617_0001493152-25-014925_ex4-1.htm:1]** **[926617_0001493152-25-014925_ex4-1.htm:3]**

AWHL Amends Securities Purchase Agreement and Warrant Terms

- Aspira Women's Health Inc. announced an equity capital infusion totaling **$3.06 million** from existing and new investors.  **[926617_0001493152-25-013987_ex99-1.htm:0]** 
- This infusion comprises a **$2.95 million** private placement and a **$112,500** warrant exercise.  **[926617_0001493152-25-013987_ex99-1.htm:0]** 
- The private placement, which closed on **September 17, 2025**, involved the issuance of **6,550,000 additional common shares** and **4,912,500 new warrants** at a unit price of **$0.45**.  **[926617_0001493152-25-013987_ex99-1.htm:0]** **[926617_0001493152-25-013987_form8-k.htm:1]** 
- The warrants are exercisable at **$0.75** per share and have a **five-year** term.  **[926617_0001493152-25-013987_ex99-1.htm:0]** **[926617_0001493152-25-013987_form8-k.htm:1]** 
- Net proceeds from the offering will be used to support ongoing commercial activities, general corporate purposes, and working capital.  **[926617_0001493152-25-013987_ex99-1.htm:0]** **[926617_0001493152-25-013987_form8-k.htm:1]** **[926617_0001493152-25-013987_ex10-1.htm:26]**

Aspira Women's Health (AWHL)